Skip to main content

Table 2 Median prices of anti-malarials being sold in the public, private and NGO sector

From: Access to artesunate-amodiaquine, quinine and other anti-malarials: policy and markets in Burundi

 

Public sector

Private sector

NGO sector

 

No. of anti-malarials

Median price (range) US$

No. of anti-malarials

Median price (range) US$

No. of anti-malarials

Median price (range) US$

ASAQ

28

0.16 (0.16-0.16)

19

0.56 (0.16-2.82)

15

0.16 (0.08-2.42)

Quinine

53

0.59 (0.03-1.77)

73

1.09 (0.24-3.39)

25

1.19 (0.16-2.58)

   Quinine injection

19

0.24 (0.12-0.48)

25

0.36 (0.24-1.61)

9

0.32 (0.16-0.81)

   Quinine tablet

34

1.53 (0.03-1.77)

48

1.61 (0.32-3.39)

16

1.61 (0.51-2.58)

Non-policy anti-malarials

2

8.90 (0.32-11.29)a

19

8.55 (8.35-9.44)

0

 
  1. ACT, artemisinin combination therapies; US$, United States Dollars
  2. Anti-malarials that were offered for free (n = 4; 1 ACT, 1 quinine injection, and 2 quinine tablets) were excluded from median price calculations.
  3. aMean was calculated since there were only two other anti-malarials available in the public sector. According to WHO-HAI methods, there should be at ≥4 medicines to calculate the median.
Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us